Electrolyte disorders Flashcards
Assessment of electrolyte imbalance
-Laboratory results
-History
=Vomiting (hypokalaemia, metabolic alkalosis), diarrhoea (hypokalaemia, metabolic alkalosis/acidosis), weakness (hypo/hyperkalaemia), confusion (hyponatremia, hypercalcaemia), pain (hypercalcaemia), endocrine and renal disease (excretion), alcohol, diet, supplements
-Physical examination
=BP (potassium in aldosteronism), fluid status, endocrine disease?
-Complete drug history!
Why is hyperkalaemia important?
-Life-threatening cardiac dysrhythmia.
-Potassium is freely filtered at the glomerulus; around 65% is reabsorbed in the proximal tubule and a further 25% in the thick ascending limb of the loop of Henle.
-Little potassium is transported in the early distal tubule but a significant secretory flux of potassium into the urine occurs in the late distal tubule and cortical collecting duct to ensure that the amount removed from the blood is proportional to the ingested load.
Causes of hyperkalaemia
-AKI
-Drugs:
=potassium sparing diuretics
=ACE inhibitors
=Angiotensin 2 receptor blockers
=Spironolactone
=Ciclosporin
=Heparin
-Metabolic acidosis
-Addison’s disease
-Rhabdomyolysis
-Massive blood transfusion
Presentation of hyperkalaemia
-Mild to moderate hyperkalaemia (<6.5 mmol/L) is usually asymptomatic.
-More severe hyperkalaemia can present with progressive muscular weakness, but sometimes there are no symptoms until cardiac arrest occurs.
-Metabolic acidosis is associated with hyperkalaemia as hydrogen and potassium ions compete with each other for exchange with sodium ions across cell membranes and in the distal tubule.
Investigation of hyperkalaemia
-ECG: monitor cardiac rhythm serum K >/6.0 mmol/l
=Clinical signs are rare. An ECG may show tall T waves (peaked, 5.8), increased PR interval (6.5) and widened QRS complexes (7+). In severe cases, the P and T waves are absent (7+). A plasma K+ of over 7 mmol/l may lead to cardiac arrest. Sine wave, bradycardia, VT
-Exclude pseudo hyperkalaemia
-Electrolytes, creatinine, bicarbonate
-Plasma sodium concentration in Addison’s
Mild: 5.5-5.9
Moderate: 6-6.4
Severe: >6.5
Rate of rise
Management of hyperkalaemia
- Stabilising cardiac conduction (with intravenous calcium salts, chloride central 10mg 10%/gluconate peripheral 30 10%) IMMEDIATE PRIORITY, repeat every 2-3 minutes
- Shifting potassium into cells (a temporary holding measure):
=insulin-dextrose (10 units soluble in 25g glucose: 250ml 10% if no pulmonary oedema, monitor BM, 30 mins for 2 hours then every hour for 6 hours)
=salbutamol (nebulised 20mg)
=possibly sodium bicarbonate (cardiac arrest)
=restore renal function (IV fluids? urinary catheter?) - Enhancing potassium removal from the body (in the urine or using renal replacement therapy, IV furosemide? with normal saline)
-For mild-to-moderate hyperkalaemia, it is important to weigh the benefits of potassium-lowering therapy against the iatrogenic risks. =These risks include hypoglycaemia (after insulin therapy) and decompensated heart failure (after stopping RAS inhibitors).
-Longer-term
=Dietary restriction
=Binders
=Diuretics
=Review RASi and other medications
Describe giving IV calcium
-Intravenous calcium is necessary only if there is dysrhythmia or severe ECG changes
=10% gluconate or chloride, 10mls over 5 minutes (maximum 2mls/min)
-Give if ECG changes – peaked T-waves, prolonged PR
-Check in 15 minutes and if still abnormal, repeat once or twice
-Does not change [K+]; reduces excitability of membranes
Describe giving IV dextrose and insulin
-Intravenous glucose (dextrose)
-50ml 50% (25g) + 5u Actrapid over 20 minutes (i.e., maximum ratio of 5g:1 unit)
-Acts in 30 minutes, peak effect 90 minutes, lasts up to 6 hours
-Lowers [K+] by 0.7-1.6mmol/l
-Can be followed by slow infusion of 10-50% dextrose (give insulin only if glucose high)
-Monitor blood sugar after administration
Describe giving salbutamol
-5mg nebulised
-Acts in 60 minutes, peaks 90 minutes, lasts up to 6 hours
-Similar to dextrose in efficacy
Describe giving sodium bicarbonate
-Sodium bicarbonate
-50 mmol, usually as 330mls 1.26% (isotonic) (50ml of 8.4%, but this is irritant)
-The least effective intervention and involves sodium load; consider if acidotic and extra sodium tolerable
-Can reduce [K+] by 0.2-0.3mmol/l
-Not routine but may be useful in emergency
Describe giving dialysis
-Dialysis
-Only necessary if renal function very poor – working kidneys excrete potassium!
-Note that above treatments do not remove, they only redistribute [K+]
-A standard haemodialysis removes 40-60mmol [K+]
-Haemodialysis lowers [K+] faster than haemofiltration or peritoneal dialysis
Describe giving potassium binding resins and compounds
Calcium Resonium is the original. Not useful in acute setting but may be short/medium term option if dialysis not desirable or possible. Unpleasant to take, causes constipation, limited effectiveness. Other more effective and apparently less toxic compounds are in development.
Hyperkalaemia in cardiac arrest
- ALS
- Identify and treat reversible causes
- Calcium chloride or calcium gluconate IV bolus (repeat 5-10 mins)
- Insulin-glucose IV bolus (follow with 10% glucose infusion if BM <7)
- Sodium bicarbonate IV bolus
ROSC achieved?
=Dialysis
=Monitor serum K and BM
=Post cardiac arrest management, ICU
Hyperkalaemia in primary care
5.5-5.9
=Medication review (RAASi, potassium supplements, trimethoprim, NSAID, non-selective beta blockers)
=Low K diet, treat metabolic acidosis, consider diuretic (Patiromer, Sodium Zirconium Cyclosilicate)
6-6.4
=If not acutely ill or AKI, medication review
==Ig CKD 3b-5 or HF, Patiromer or SZC
==Stop RAASi
=If acutely ill, stop RAASi and refer to hospital for emergency treatment
(hyper)Potassium homeostasis
-Serum K sensed in adrenal cortex
-Adrenal gland makes aldosterone= reabsorb sodium and excrete potassium (GFR, tubular flow to distal nephron, K secretion exchange for Na so function of collecting duct)
-Shift in plasma potassium: insulin, catecholamines, acid-base, integrity of cells
85% of normal potassium excretion is in urine. Potassium balance depends on regulation of urinary excretion. Endogenous potassium is largely intracellular, hence changes in K+ distribution between ECF and ICF may greatly affect plasma K+ concentration.
Causes of hyperkalaemia
-Increased intake (food, IV fluids, potassium supplements)(unlikely to be sole cause)
-Tissue breakdown (e.g. tissue damage, bleeding, haemolysis, rhabdomyolysis, tumour lysis)
-K+ release from cells (e.g. in hyperglycaemia, acidosis)
-Endocrine – Addison’s disease/ adrenal insufficiency (aldosterone)
Impaired excretion in urine (e.g. in renal failure/ advanced CKD, and with drugs – ACE inhibitors, potassium-sparing diuretics, AKI)
DRUGS
-Impaired aldosterone signalling
=ACEi/ARB
=beta blockers
=heparin
-Impaired renal Na/K exchange
=K-sparing diuretics
=Trimethoprim (co-trimoxazole)
=CNI
-Cellular translocation
=Beta-blockers
=Digoxin
=Anaesthetic agents
=Mannitol
Low potassium diet
-The usual dietary intake of K+ is about 80 mmol/day.
-Typical daily intake in the UK can vary from 50 to 150mmol. Intake should only be limited if blood tests show it’s necessary, as the fruit and vegetable contribution to potassium intake is important for general health.
Potassium is found in many foods but particularly high in fruit, fruit juice, and potatoes and vegetables which have not been boiled. Salt substitutes (i.e. Contain potassium rather than sodium), bananas, oranges, kiwi fruit, avocado, spinach, tomatoes
CKD – restriction not usually required until GFR<20, unless on ACE inhibitions, and their continuation thought important.
HD – most patients require some restriction.
PD – some patients require restriction.
Causes of hypokalaemia
- SHIFT INTO CELLS
-catecholamines / beta-agonists
-insulin treatment of hyperglycaemia
-re-feeding syndrome
-hypokalaemic periodic paralysis
-metabolic alkalosis - RENAL POTASSIUM LOSS
-with metabolic alkalosis
=vomiting, diuretics, Gitelman, Bartter, mineralocorticoid XS, apparent mineralocorticoid XS
-with metabolic acidosis
=renal tubular acidosis types I & II
=DKA
-with variable acid-base
=Mg-depletion
=non-reabsorbable anion (e.g. high-dose IV penicillins) - GASTROINTESTINAL POTASSIUM LOSS
-with normal acid-base
=anorexia, tea & toast diet, laxative abuse
-with metabolic acidosis
=diarrhoea, villous adenoma, intestinal obstruction
ENDOCRINE: hyperaldosteronism, primary or secondary
-Hypokalaemia with hypertension
=Cushing’s syndrome
=Conn’s syndrome (primary hyperaldosteronism)
=Liddle’s syndrome
=11-beta hydroxylase deficiency*
-Hypokalaemia without hypertension
=Diuretics
=GI loss (e.g. Diarrhoea, vomiting)
=Renal tubular acidosis (type 1 and 2**)
=Bartter’s syndrome
=Gitelman syndrome
-Hypokalaemia with alkalosis
=Vomiting
=Thiazide and loop diuretics
=Cushing’s syndrome
=Conn’s syndrome (primary hyperaldosteronism)
-Hypokalaemia with acidosis
=Diarrhoea
=Renal tubular acidosis
=Acetazolamide
=Partially treated diabetic ketoacidosis
Presentation of hypokalaemia
-Patients with mild hypokalaemia (plasma K + 3.0–3.5 mmol/L) are generally asymptomatic
-Lethargy
-Muscle weakness
-Tingling in fingers, paralysis and coma are present in more severe cases.
-Ventricular ectopic beats or more serious arrhythmias may occur and the arrhythmogenic effects of digoxin may be potentiated
-In chronic hypokalaemia there may be nocturia, polyuria or polydipsia.
muscle weakness, hypotonia
hypokalaemia predisposes patients to digoxin toxicity - care should be taken if patients are also on diuretics
Investigation in hypokalaemia
-The urine potassium concentration or 24 hr urine potassium excretion can be helpful in distinguishing between renal and extra-renal causes of hypokalaemia. Urine potassium is
=Low (< 20 mM on a spot sample or < 15 – 20 mmoles per day) in extra-renal causes
=High (> 20 mM on a spot sample or > 15 – 20 mmoles per day) in renal causes.
-One important thing to remember here is that vomiting actually promotes renal potassium loss, so expect a high urine potassium concentration after vomiting.
-Plasma electrolytes, bicarbonate, urine potassium, plasma calcium and magnesium, plasma renin?
-Many such cases are associated with metabolic alkalosis, and in this setting the measurement of urine chloride concentration can be helpful. A low urine chloride (<30 mmol/L) is characteristic of vomiting (spontaneous or self-induced, in which chloride is lost in HCl in the vomit), while a urine chloride >40 mmol/L suggests diuretic therapy (acute phase) or a tubular disorder such as Bartter or Gitelman syndromes. Differentiation between occult diuretic use and primary tubular disorders can be achieved by performing a screen of urine for diuretic drugs.
U waves
small or absent T waves (occasionally inversion)
prolong PR interval
ST depression
long QT
=In Hypokalaemia, U have no Pot and no T, but a long PR and a long QT
Management of hypokalaemia
-KCl, intravenously in severe cases
-Correcting any associated salt and water imbalance.
-Recurrence is prevented by encouraging a K+ rich diet, but K+ supplementation or a K+-sparing diuretic is advisable if the patient requires diuretics, and supplementation if receiving intravenous fluid treatment.
-In the less common situation where hypokalaemia occurs in the presence of metabolic acidosis, alkaline salts of potassium, such as potassium bicarbonate, can be given by mouth.
-If magnesium depletion is also present, replacement of magnesium may also be required, since low cellular magnesium can promote tubular potassium secretion, causing ongoing urinary losses.
- In some circumstances, potassium-sparing diuretics, such as amiloride, can assist in the correction of hypokalaemia, hypomagnesaemia and metabolic alkalosis, especially when renal loss of potassium is the underlying cause.
Why is sodium balance important?
Serum sodium concentration reflects the balance between total body sodium and total body water content. Hence, an assessment of fluid status is key to determining the aetiology and treatment of disorders of sodium concentration. Both hyponatraemia and hypernatraemia can cause cerebral damage, therefore it is important to know the causes and management of disorders of sodium concentration
Homeostatic control of sodium
-Plasma tonicity (sensed by osmoreceptors in hypothalamus) is controlled in a negative-feedback loop in which anti-diuretic hormone (ADH) is released from the posterior pituitary in response to rising tonicity.
-ADH acts in the collecting ducts of the kidney, opposing the excretion of water in the urine (make concentrated urine)
-Renal free water excretion depends on: GFR, diluting segment (ascending limb, DCT), ADH-receptor-responsive CDs, osmolar load (amount solute intake)
-Plasma sodium proportional to total body solute content (Na + K)/ total body water
Causes of hypernatraemia
-The problem is a deficit in total body water.
=As thirst is such a powerful mechanism, this situation usually only arises in patients who have no access to water (e.g. in the perioperative setting)
- Reduced water intake (e.g. coma, dysphagia, extreme depression). Because hypernatraemia is an extremely strong stimulus to thirst, reduced water intake is almost always involuntary.
- And increased losses of hypotonic fluid. Usually both are present, though either alone can be sufficient.
=increased loss via gut, skin or respiratory tract. Cholera syndromes (likely to be sodium depleted too); severe sweating, etc
=increased loss in urine caused by impaired ability to concentrate urine (diabetes insipidus, central, nephrogenic or drug-induced)
osmotic diuresis e.g. hyperosmolar non-ketotic diabetic coma
diabetes insipidus
excess IV saline